Type 2 Diabetes (T2DM) trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All Type 2 Diabetes (T2DM) trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
  NCT07219602 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Bridgeton